Search

Your search keyword '"Lakatos, P.L."' showing total 156 results

Search Constraints

Start Over You searched for: Author "Lakatos, P.L." Remove constraint Author: "Lakatos, P.L."
156 results on '"Lakatos, P.L."'

Search Results

3. Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: Results of the 2011 ECCO-EpiCom inception cohort

4. Health-related quality of life improves during one year of medical and surgical treatment in a European population-based inception cohort of patients with Inflammatory Bowel Disease — An ECCO-EpiCom study

5. Health care and patients' education in a European inflammatory bowel disease inception cohort: An ECCO-EpiCom study

6. Environmental factors in a population-based inception cohort of inflammatory bowel disease patients in Europe — An ECCO-EpiCom study

7. P695 The risk of proximal disease extension in patients with limited ulcerative colitis in a prospective European population-based inception cohort – the ECCO-EpiCom cohort

8. P727 Change in Crohnʼs disease behavior in a prospective European population-based inception cohort – the ECCO-EpiCom cohort

9. P734 The sex ratio of inflammatory bowel disease varies according to age at onset: results from a worldwide survey

10. P694 Disease course during the first five years following diagnosis in a prospective European population-based inception cohort – the ECCO-EpiCom cohort

13. P592 Final results on immunogenicity profile and predictors of ADA development of biosimilar infliximab during the first 12 months of the therapy: results from a prospective nationwide cohort

22. Gender-stratified analysis of DLG5 R30Q in 4707 patients with Crohn disease and 4973 controls from 12 caucasian cohorts

26. ECCO Position statement on the use of biosimilars for inflammatory bowel disease-an update

27. 3rd European evidence-based consensus on the diagnosis and management of Crohn's disease 2016: Part 2: Surgical management and special situations

28. The First European Evidence-Based Consensus on Extra-Intestinal Manifestations in Inflammatory Bowel Disease

31. Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic Resection

32. East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort

33. P557 Antibody and cell-mediated immune response to whole virion and split virion influenza vaccine in patients with inflammatory bowel disease on maintenance immunosuppressive and biological therapy

34. P321 The one-year efficacy of infliximab does not depend on the timing of biological therapy in ulcerative colitis

36. DOP028 Development of red flags for early referral of adults with symptoms and signs suggestive of Crohn's disease: an IOIBD initiative

38. P344 Short and medium term efficacy of adalimumab in ulcerative colitis – a multicentre, prospective observational study

39. High serum osteoprotegerin and low RANKL in primary biliary cirrhosis

40. The management of iron deficiency in inflammatory bowel disease

44. 183 MANNOSE-BINDING LECTIN DEFICIENCY CONFERS RISK FOR INFECTIONS IN A LARGE HUNGARIAN COHORT OF PATIENTS WITH LIVER CIRRHOSIS

47. P129 - The impact of concomitant treatment with immuno-modulators and antibiotics on the outcome of C. difficile-associated inflammatory bowel disease exacerbation: an ECCO multi-center retrospective study

49. P295 - MBL level and deficiency is not associated with either Crohn's disease or ulcerative colitis, disease phenotype, CRP, serology profile and NOD2/CARD15 genotype in a large Hungarian IBD cohort, but was associated to the lack of TLR4 variants in CD

50. P015 - Pancreatic autoantibodies are associated with reactivity to microbial antibodies penetrating disease behavior perianal disease and extraintestinal manifestations but not with NOD2/CARD15 or TLR4 genotype in a Hungarian IBD cohort

Catalog

Books, media, physical & digital resources